PubMed:17255138
Annnotations
LitCoin-entities
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| 3881 | 22-38 | ChemicalEntity | denotes | COX-2 inhibitors | MESH:D052246 |
| 3882 | 56-62 | ChemicalEntity | denotes | NSAIDs | MESH:D000894 |
| 3883 | 188-215 | DiseaseOrPhenotypicFeature | denotes | acute myocardial infarction | MESH:D009203 |
| 3884 | 217-220 | DiseaseOrPhenotypicFeature | denotes | AMI | MESH:D009203 |
| 3885 | 227-243 | ChemicalEntity | denotes | COX-2 inhibitors | MESH:D052246 |
| 3886 | 324-361 | ChemicalEntity | denotes | non-steroidal anti-inflammatory drugs | MESH:D000894 |
| 3887 | 363-369 | ChemicalEntity | denotes | NSAIDs | MESH:D000894 |
| 3888 | 425-428 | DiseaseOrPhenotypicFeature | denotes | AMI | MESH:D009203 |
| 3889 | 433-444 | DiseaseOrPhenotypicFeature | denotes | GI bleeding | MESH:D006471 |
| 3890 | 474-490 | ChemicalEntity | denotes | COX-2 inhibitors | MESH:D052246 |
| 3891 | 495-501 | ChemicalEntity | denotes | NSAIDs | MESH:D000894 |
| 3892 | 506-519 | ChemicalEntity | denotes | acetaminophen | MESH:D000082 |
| 3893 | 662-667 | ChemicalEntity | denotes | NSAID | MESH:D000894 |
| 3894 | 671-684 | ChemicalEntity | denotes | acetaminophen | MESH:D000082 |
| 3895 | 838-845 | ChemicalEntity | denotes | aspirin | MESH:D001241 |
| 3896 | 862-875 | ChemicalEntity | denotes | acetaminophen | MESH:D000082 |
| 3897 | 887-896 | ChemicalEntity | denotes | rofecoxib | MESH:C116926 |
| 3898 | 907-916 | ChemicalEntity | denotes | celecoxib | MESH:C105934 |
| 3899 | 935-941 | ChemicalEntity | denotes | NSAIDs | MESH:D000894 |
| 3900 | 958-965 | ChemicalEntity | denotes | aspirin | MESH:D001241 |
| 3901 | 988-997 | ChemicalEntity | denotes | rofecoxib | MESH:C116926 |
| 3902 | 1009-1018 | ChemicalEntity | denotes | celecoxib | MESH:C105934 |
| 3903 | 1032-1038 | ChemicalEntity | denotes | NSAIDs | MESH:D000894 |
| 3904 | 1053-1066 | ChemicalEntity | denotes | acetaminophen | MESH:D000082 |
| 3905 | 1087-1094 | ChemicalEntity | denotes | aspirin | MESH:D001241 |
| 3906 | 1172-1175 | DiseaseOrPhenotypicFeature | denotes | AMI | MESH:D009203 |
| 3907 | 1186-1199 | ChemicalEntity | denotes | acetaminophen | MESH:D000082 |
| 3908 | 1209-1216 | ChemicalEntity | denotes | aspirin | MESH:D001241 |
| 3909 | 1230-1239 | ChemicalEntity | denotes | rofecoxib | MESH:C116926 |
| 3910 | 1259-1268 | ChemicalEntity | denotes | celecoxib | MESH:C105934 |
| 3911 | 1288-1296 | ChemicalEntity | denotes | naproxen | MESH:D009288 |
| 3912 | 1316-1326 | ChemicalEntity | denotes | diclofenac | MESH:D004008 |
| 3913 | 1349-1358 | ChemicalEntity | denotes | ibuprofen | MESH:D007052 |
| 3914 | 1393-1400 | ChemicalEntity | denotes | aspirin | MESH:D001241 |
| 3915 | 1413-1422 | ChemicalEntity | denotes | rofecoxib | MESH:C116926 |
| 3916 | 1442-1451 | ChemicalEntity | denotes | celecoxib | MESH:C105934 |
| 3917 | 1471-1480 | ChemicalEntity | denotes | ibuprofen | MESH:D007052 |
| 3918 | 1500-1510 | ChemicalEntity | denotes | diclofenac | MESH:D004008 |
| 3919 | 1530-1538 | ChemicalEntity | denotes | naproxen | MESH:D009288 |
| 3920 | 1561-1574 | ChemicalEntity | denotes | acetaminophen | MESH:D000082 |
| 3921 | 1625-1632 | ChemicalEntity | denotes | aspirin | MESH:D001241 |
| 3922 | 1634-1642 | ChemicalEntity | denotes | naproxen | MESH:D009288 |
| 3923 | 1680-1683 | DiseaseOrPhenotypicFeature | denotes | AMI | MESH:D009203 |
| 3924 | 1684-1695 | DiseaseOrPhenotypicFeature | denotes | GI bleeding | MESH:D006471 |
| 3925 | 1701-1704 | DiseaseOrPhenotypicFeature | denotes | AMI | MESH:D009203 |
| 3926 | 1705-1716 | DiseaseOrPhenotypicFeature | denotes | GI toxicity | MESH:D005767 |
| 3927 | 1720-1729 | ChemicalEntity | denotes | celecoxib | MESH:C105934 |
| 3928 | 1753-1766 | ChemicalEntity | denotes | acetaminophen | MESH:D000082 |
| 3929 | 1805-1814 | ChemicalEntity | denotes | rofecoxib | MESH:C116926 |
| 3930 | 1822-1828 | ChemicalEntity | denotes | NSAIDs | MESH:D000894 |
| 3931 | 1845-1852 | ChemicalEntity | denotes | aspirin | MESH:D001241 |
| 3932 | 1859-1868 | ChemicalEntity | denotes | celecoxib | MESH:C105934 |
| 3933 | 1873-1881 | ChemicalEntity | denotes | naproxen | MESH:D009288 |
LitCoin-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-133 | Sentence | denotes | Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? |
| T2 | 134-163 | Sentence | denotes | A retrospective cohort study. |
| T3 | 164-175 | Sentence | denotes | OBJECTIVES: |
| T4 | 176-371 | Sentence | denotes | The risk of acute myocardial infarction (AMI) with COX-2 inhibitors may offset their gastrointestinal (GI) benefit compared with non-selective (NS) non-steroidal anti-inflammatory drugs (NSAIDs). |
| T5 | 372-520 | Sentence | denotes | We aimed to compare the risks of hospitalization for AMI and GI bleeding among elderly patients using COX-2 inhibitors, NS-NSAIDs and acetaminophen. |
| T6 | 521-529 | Sentence | denotes | METHODS: |
| T7 | 530-702 | Sentence | denotes | We conducted a retrospective cohort study using administrative data of patients > or =65 years of age who filled a prescription for NSAID or acetaminophen during 1999-2002. |
| T8 | 703-784 | Sentence | denotes | Outcomes were compared using Cox regression models with time-dependent exposures. |
| T9 | 785-793 | Sentence | denotes | RESULTS: |
| T10 | 794-851 | Sentence | denotes | Person-years of exposure among non-users of aspirin were: |
| T11 | 852-942 | Sentence | denotes | 75,761 to acetaminophen, 42,671 to rofecoxib 65,860 to celecoxib, and 37,495 to NS-NSAIDs. |
| T12 | 943-977 | Sentence | denotes | Among users of aspirin, they were: |
| T13 | 978-1067 | Sentence | denotes | 14,671 to rofecoxib, 22,875 to celecoxib, 9,832 to NS-NSAIDs and 38,048 to acetaminophen. |
| T14 | 1068-1377 | Sentence | denotes | Among non-users of aspirin, the adjusted hazard ratios (95% confidence interval) of hospitalization for AMI/GI vs the acetaminophen (with no aspirin) group were: rofecoxib 1.27 (1.13, 1.42), celecoxib 0.93 (0.83, 1.03), naproxen 1.59 (1.31, 1.93), diclofenac 1.17 (0.99, 1.38) and ibuprofen 1.05 (0.74, 1.51). |
| T15 | 1378-1593 | Sentence | denotes | Among users of aspirin, they were: rofecoxib 1.73 (1.52, 1.98), celecoxib 1.34 (1.19, 1.52), ibuprofen 1.51 (0.95, 2.41), diclofenac 1.69 (1.35, 2.10), naproxen 1.35 (0.97, 1.88) and acetaminophen 1.29 (1.17, 1.42). |
| T16 | 1594-1605 | Sentence | denotes | CONCLUSION: |
| T17 | 1606-1696 | Sentence | denotes | Among non-users of aspirin, naproxen seemed to carry the highest risk for AMI/GI bleeding. |
| T18 | 1697-1829 | Sentence | denotes | The AMI/GI toxicity of celecoxib was similar to that of acetaminophen and seemed to be better than those of rofecoxib and NS-NSAIDs. |
| T19 | 1830-1911 | Sentence | denotes | Among users of aspirin, both celecoxib and naproxen seemed to be the least toxic. |
LitCoin_Mondo
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 188-215 | DiseaseOrPhenotypicFeature | denotes | acute myocardial infarction | 0004781 |
| T2 | 194-215 | DiseaseOrPhenotypicFeature | denotes | myocardial infarction | 0005068 |
LitCoin-GeneOrGeneProduct-v0
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 22-27 | GeneOrGeneProduct | denotes | COX-2 |
| T2 | 28-38 | GeneOrGeneProduct | denotes | inhibitors |
| T3 | 217-220 | GeneOrGeneProduct | denotes | AMI |
| T4 | 227-232 | GeneOrGeneProduct | denotes | COX-2 |
| T5 | 233-243 | GeneOrGeneProduct | denotes | inhibitors |
| T6 | 279-281 | GeneOrGeneProduct | denotes | GI |
| T7 | 425-428 | GeneOrGeneProduct | denotes | AMI |
| T8 | 433-435 | GeneOrGeneProduct | denotes | GI |
| T9 | 474-479 | GeneOrGeneProduct | denotes | COX-2 |
| T10 | 480-490 | GeneOrGeneProduct | denotes | inhibitors |
| T11 | 521-528 | GeneOrGeneProduct | denotes | METHODS |
| T12 | 612-618 | GeneOrGeneProduct | denotes | or =65 |
| T13 | 619-624 | GeneOrGeneProduct | denotes | years |
| T14 | 636-642 | GeneOrGeneProduct | denotes | filled |
| T15 | 759-763 | GeneOrGeneProduct | denotes | time |
| T16 | 801-806 | GeneOrGeneProduct | denotes | years |
| T17 | 1172-1175 | GeneOrGeneProduct | denotes | AMI |
| T18 | 1176-1178 | GeneOrGeneProduct | denotes | GI |
| T19 | 1680-1683 | GeneOrGeneProduct | denotes | AMI |
| T20 | 1684-1686 | GeneOrGeneProduct | denotes | GI |
| T21 | 1697-1704 | GeneOrGeneProduct | denotes | The AMI |
| T22 | 1705-1707 | GeneOrGeneProduct | denotes | GI |
| T23 | 1734-1741 | GeneOrGeneProduct | denotes | similar |
LitCoin-GeneOrGeneProduct-v2
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 22-27 | GeneOrGeneProduct | denotes | COX-2 |
| T2 | 28-38 | GeneOrGeneProduct | denotes | inhibitors |
| T3 | 227-232 | GeneOrGeneProduct | denotes | COX-2 |
| T4 | 233-243 | GeneOrGeneProduct | denotes | inhibitors |
| T5 | 474-479 | GeneOrGeneProduct | denotes | COX-2 |
| T6 | 480-490 | GeneOrGeneProduct | denotes | inhibitors |
| T7 | 1734-1741 | GeneOrGeneProduct | denotes | similar |
LitCoin-Disease-MeSH
| Id | Subject | Object | Predicate | Lexical cue | originalLabel |
|---|---|---|---|---|---|
| T1 | 194-215 | DiseaseOrPhenotypicFeature | denotes | myocardial infarction | D009203 |
| T2 | 343-355 | DiseaseOrPhenotypicFeature | denotes | inflammatory | DISEASE |
| T3 | 436-444 | DiseaseOrPhenotypicFeature | denotes | bleeding | D006470 |
| T4 | 1687-1695 | DiseaseOrPhenotypicFeature | denotes | bleeding | D006470 |
| T5 | 1708-1716 | DiseaseOrPhenotypicFeature | denotes | toxicity | DISEASE |
LitCoin-GeneOrGeneProduct-v3
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 22-27 | GeneOrGeneProduct | denotes | COX-2 |
| T2 | 227-232 | GeneOrGeneProduct | denotes | COX-2 |
| T3 | 474-479 | GeneOrGeneProduct | denotes | COX-2 |
LitCoin_Mondo_095
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 188-215 | DiseaseOrPhenotypicFeature | denotes | acute myocardial infarction | 0004781 |
| T2 | 217-220 | DiseaseOrPhenotypicFeature | denotes | AMI | 0004781 |
| T3 | 320-322 | DiseaseOrPhenotypicFeature | denotes | NS | 0009735 |
| T4 | 425-428 | DiseaseOrPhenotypicFeature | denotes | AMI | 0004781 |
| T5 | 433-444 | DiseaseOrPhenotypicFeature | denotes | GI bleeding | 0004242 |
| T6 | 492-494 | DiseaseOrPhenotypicFeature | denotes | NS | 0009735 |
| T7 | 932-934 | DiseaseOrPhenotypicFeature | denotes | NS | 0009735 |
| T8 | 1029-1031 | DiseaseOrPhenotypicFeature | denotes | NS | 0009735 |
| T9 | 1172-1175 | DiseaseOrPhenotypicFeature | denotes | AMI | 0004781 |
| T10 | 1680-1683 | DiseaseOrPhenotypicFeature | denotes | AMI | 0004781 |
| T11 | 1684-1695 | DiseaseOrPhenotypicFeature | denotes | GI bleeding | 0004242 |
| T12 | 1701-1704 | DiseaseOrPhenotypicFeature | denotes | AMI | 0004781 |
| T13 | 1819-1821 | DiseaseOrPhenotypicFeature | denotes | NS | 0009735 |
LitCoin-MeSH-Disease-2
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T1 | 194-215 | DiseaseOrPhenotypicFeature | denotes | myocardial infarction | D009203 |
| T2 | 217-220 | DiseaseOrPhenotypicFeature | denotes | AMI | DISEASE |
| T3 | 343-355 | DiseaseOrPhenotypicFeature | denotes | inflammatory | DISEASE |
| T4 | 425-428 | DiseaseOrPhenotypicFeature | denotes | AMI | DISEASE |
| T5 | 436-444 | DiseaseOrPhenotypicFeature | denotes | bleeding | D006470 |
| T6 | 1172-1175 | DiseaseOrPhenotypicFeature | denotes | AMI | DISEASE |
| T7 | 1680-1683 | DiseaseOrPhenotypicFeature | denotes | AMI | DISEASE |
| T8 | 1687-1695 | DiseaseOrPhenotypicFeature | denotes | bleeding | D006470 |
| T9 | 1701-1704 | DiseaseOrPhenotypicFeature | denotes | AMI | DISEASE |
| T10 | 1705-1716 | DiseaseOrPhenotypicFeature | denotes | GI toxicity | DISEASE |
LitCoin-MONDO_bioort2019
| Id | Subject | Object | Predicate | Lexical cue | #label |
|---|---|---|---|---|---|
| T1 | 194-215 | DiseaseOrPhenotypicFeature | denotes | myocardial infarction | D009203 |
| T2 | 217-220 | DiseaseOrPhenotypicFeature | denotes | AMI | DISEASE |
| T3 | 425-428 | DiseaseOrPhenotypicFeature | denotes | AMI | DISEASE |
| T4 | 436-444 | DiseaseOrPhenotypicFeature | denotes | bleeding | D006470 |
| T5 | 1172-1175 | DiseaseOrPhenotypicFeature | denotes | AMI | DISEASE |
| T6 | 1680-1683 | DiseaseOrPhenotypicFeature | denotes | AMI | DISEASE |
| T7 | 1687-1695 | DiseaseOrPhenotypicFeature | denotes | bleeding | D006470 |
| T8 | 1701-1704 | DiseaseOrPhenotypicFeature | denotes | AMI | DISEASE |
| T9 | 1705-1716 | DiseaseOrPhenotypicFeature | denotes | GI toxicity | DISEASE |
LitCoin-Chemical-MeSH-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T1 | 22-38 | ChemicalEntity | denotes | COX-2 inhibitors | ChemicalEntity |
| T2 | 56-62 | ChemicalEntity | denotes | NSAIDs | ChemicalEntity |
| T3 | 217-220 | ChemicalEntity | denotes | AMI | http://purl.obolibrary.org/obo/CHEBI_65009 |
| T4 | 227-243 | ChemicalEntity | denotes | COX-2 inhibitors | ChemicalEntity |
| T5 | 324-361 | ChemicalEntity | denotes | non-steroidal anti-inflammatory drugs | ChemicalEntity |
| T6 | 363-369 | ChemicalEntity | denotes | NSAIDs | ChemicalEntity |
| T7 | 425-428 | ChemicalEntity | denotes | AMI | http://purl.obolibrary.org/obo/CHEBI_65009 |
| T8 | 474-490 | ChemicalEntity | denotes | COX-2 inhibitors | ChemicalEntity |
| T9 | 495-501 | ChemicalEntity | denotes | NSAIDs | ChemicalEntity |
| T10 | 506-519 | ChemicalEntity | denotes | acetaminophen | D000082 |
| T11 | 662-667 | ChemicalEntity | denotes | NSAID | ChemicalEntity |
| T12 | 671-684 | ChemicalEntity | denotes | acetaminophen | D000082 |
| T13 | 838-845 | ChemicalEntity | denotes | aspirin | D001241 |
| T14 | 862-875 | ChemicalEntity | denotes | acetaminophen | D000082 |
| T15 | 887-896 | ChemicalEntity | denotes | rofecoxib | C116926|http://purl.obolibrary.org/obo/CHEBI_8887 |
| T17 | 907-916 | ChemicalEntity | denotes | celecoxib | D000068579|http://purl.obolibrary.org/obo/CHEBI_41423 |
| T19 | 935-941 | ChemicalEntity | denotes | NSAIDs | ChemicalEntity |
| T20 | 958-965 | ChemicalEntity | denotes | aspirin | D001241 |
| T21 | 988-997 | ChemicalEntity | denotes | rofecoxib | C116926|http://purl.obolibrary.org/obo/CHEBI_8887 |
| T23 | 1009-1018 | ChemicalEntity | denotes | celecoxib | D000068579|http://purl.obolibrary.org/obo/CHEBI_41423 |
| T25 | 1032-1038 | ChemicalEntity | denotes | NSAIDs | ChemicalEntity |
| T26 | 1053-1066 | ChemicalEntity | denotes | acetaminophen | D000082 |
| T27 | 1087-1094 | ChemicalEntity | denotes | aspirin | D001241 |
| T28 | 1172-1175 | ChemicalEntity | denotes | AMI | http://purl.obolibrary.org/obo/CHEBI_65009 |
| T29 | 1186-1199 | ChemicalEntity | denotes | acetaminophen | D000082 |
| T30 | 1209-1216 | ChemicalEntity | denotes | aspirin | D001241 |
| T31 | 1230-1239 | ChemicalEntity | denotes | rofecoxib | C116926|http://purl.obolibrary.org/obo/CHEBI_8887 |
| T33 | 1259-1268 | ChemicalEntity | denotes | celecoxib | D000068579|http://purl.obolibrary.org/obo/CHEBI_41423 |
| T35 | 1288-1296 | ChemicalEntity | denotes | naproxen | D009288|http://purl.obolibrary.org/obo/CHEBI_7476|http://purl.obolibrary.org/obo/CHEBI_59527 |
| T38 | 1316-1326 | ChemicalEntity | denotes | diclofenac | D004008|http://purl.obolibrary.org/obo/CHEBI_47381 |
| T40 | 1349-1358 | ChemicalEntity | denotes | ibuprofen | D007052|http://purl.obolibrary.org/obo/CHEBI_5855|http://purl.obolibrary.org/obo/CHEBI_132922 |
| T43 | 1393-1400 | ChemicalEntity | denotes | aspirin | D001241 |
| T44 | 1413-1422 | ChemicalEntity | denotes | rofecoxib | C116926|http://purl.obolibrary.org/obo/CHEBI_8887 |
| T46 | 1442-1451 | ChemicalEntity | denotes | celecoxib | D000068579|http://purl.obolibrary.org/obo/CHEBI_41423 |
| T48 | 1471-1480 | ChemicalEntity | denotes | ibuprofen | D007052|http://purl.obolibrary.org/obo/CHEBI_5855|http://purl.obolibrary.org/obo/CHEBI_132922 |
| T51 | 1500-1510 | ChemicalEntity | denotes | diclofenac | D004008|http://purl.obolibrary.org/obo/CHEBI_47381 |
| T53 | 1530-1538 | ChemicalEntity | denotes | naproxen | D009288|http://purl.obolibrary.org/obo/CHEBI_7476|http://purl.obolibrary.org/obo/CHEBI_59527 |
| T56 | 1561-1574 | ChemicalEntity | denotes | acetaminophen | D000082 |
| T57 | 1625-1632 | ChemicalEntity | denotes | aspirin | D001241 |
| T58 | 1634-1642 | ChemicalEntity | denotes | naproxen | D009288|http://purl.obolibrary.org/obo/CHEBI_7476|http://purl.obolibrary.org/obo/CHEBI_59527 |
| T61 | 1680-1683 | ChemicalEntity | denotes | AMI | http://purl.obolibrary.org/obo/CHEBI_65009 |
| T62 | 1701-1704 | ChemicalEntity | denotes | AMI | http://purl.obolibrary.org/obo/CHEBI_65009 |
| T63 | 1720-1729 | ChemicalEntity | denotes | celecoxib | D000068579|http://purl.obolibrary.org/obo/CHEBI_41423 |
| T65 | 1753-1766 | ChemicalEntity | denotes | acetaminophen | D000082 |
| T66 | 1805-1814 | ChemicalEntity | denotes | rofecoxib | C116926|http://purl.obolibrary.org/obo/CHEBI_8887 |
| T68 | 1822-1828 | ChemicalEntity | denotes | NSAIDs | ChemicalEntity |
| T69 | 1845-1852 | ChemicalEntity | denotes | aspirin | D001241 |
| T70 | 1859-1868 | ChemicalEntity | denotes | celecoxib | D000068579|http://purl.obolibrary.org/obo/CHEBI_41423 |
| T72 | 1873-1881 | ChemicalEntity | denotes | naproxen | D009288|http://purl.obolibrary.org/obo/CHEBI_7476|http://purl.obolibrary.org/obo/CHEBI_59527 |
LitCoin-NCBITaxon-2
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 217-220 | OrganismTaxon | denotes | AMI |
| T2 | 425-428 | OrganismTaxon | denotes | AMI |
| T3 | 459-467 | OrganismTaxon | denotes | patients |
| T4 | 601-609 | OrganismTaxon | denotes | patients |
| T5 | 1172-1175 | OrganismTaxon | denotes | AMI |
| T6 | 1680-1683 | OrganismTaxon | denotes | AMI |
| T7 | 1701-1704 | OrganismTaxon | denotes | AMI |
LitCoin-training-merged
| Id | Subject | Object | Predicate | Lexical cue | #label | ID: |
|---|---|---|---|---|---|---|
| T72 | 1873-1881 | ChemicalEntity | denotes | naproxen | http://purl.obolibrary.org/obo/CHEBI_59527|http://purl.obolibrary.org/obo/CHEBI_7476|D009288 | |
| T70 | 1859-1868 | ChemicalEntity | denotes | celecoxib | http://purl.obolibrary.org/obo/CHEBI_41423|D000068579 | |
| T69 | 1845-1852 | ChemicalEntity | denotes | aspirin | D001241 | |
| T68 | 1822-1828 | ChemicalEntity | denotes | NSAIDs | ChemicalEntity | |
| T66 | 1805-1814 | ChemicalEntity | denotes | rofecoxib | http://purl.obolibrary.org/obo/CHEBI_8887|C116926 | |
| T65 | 1753-1766 | ChemicalEntity | denotes | acetaminophen | D000082 | |
| T63 | 1720-1729 | ChemicalEntity | denotes | celecoxib | http://purl.obolibrary.org/obo/CHEBI_41423|D000068579 | |
| T62 | 1701-1704 | ChemicalEntity | denotes | AMI | http://purl.obolibrary.org/obo/CHEBI_65009 | |
| T61 | 1680-1683 | ChemicalEntity | denotes | AMI | http://purl.obolibrary.org/obo/CHEBI_65009 | |
| T58 | 1634-1642 | ChemicalEntity | denotes | naproxen | http://purl.obolibrary.org/obo/CHEBI_59527|http://purl.obolibrary.org/obo/CHEBI_7476|D009288 | |
| T57 | 1625-1632 | ChemicalEntity | denotes | aspirin | D001241 | |
| T56 | 1561-1574 | ChemicalEntity | denotes | acetaminophen | D000082 | |
| T53 | 1530-1538 | ChemicalEntity | denotes | naproxen | http://purl.obolibrary.org/obo/CHEBI_59527|http://purl.obolibrary.org/obo/CHEBI_7476|D009288 | |
| T51 | 1500-1510 | ChemicalEntity | denotes | diclofenac | http://purl.obolibrary.org/obo/CHEBI_47381|D004008 | |
| T48 | 1471-1480 | ChemicalEntity | denotes | ibuprofen | http://purl.obolibrary.org/obo/CHEBI_132922|http://purl.obolibrary.org/obo/CHEBI_5855|D007052 | |
| T46 | 1442-1451 | ChemicalEntity | denotes | celecoxib | http://purl.obolibrary.org/obo/CHEBI_41423|D000068579 | |
| T44 | 1413-1422 | ChemicalEntity | denotes | rofecoxib | http://purl.obolibrary.org/obo/CHEBI_8887|C116926 | |
| T43 | 1393-1400 | ChemicalEntity | denotes | aspirin | D001241 | |
| T40 | 1349-1358 | ChemicalEntity | denotes | ibuprofen | http://purl.obolibrary.org/obo/CHEBI_132922|http://purl.obolibrary.org/obo/CHEBI_5855|D007052 | |
| T38 | 1316-1326 | ChemicalEntity | denotes | diclofenac | http://purl.obolibrary.org/obo/CHEBI_47381|D004008 | |
| T35 | 1288-1296 | ChemicalEntity | denotes | naproxen | http://purl.obolibrary.org/obo/CHEBI_59527|http://purl.obolibrary.org/obo/CHEBI_7476|D009288 | |
| T33 | 1259-1268 | ChemicalEntity | denotes | celecoxib | http://purl.obolibrary.org/obo/CHEBI_41423|D000068579 | |
| T31 | 1230-1239 | ChemicalEntity | denotes | rofecoxib | http://purl.obolibrary.org/obo/CHEBI_8887|C116926 | |
| T30 | 1209-1216 | ChemicalEntity | denotes | aspirin | D001241 | |
| T29 | 1186-1199 | ChemicalEntity | denotes | acetaminophen | D000082 | |
| T28 | 1172-1175 | ChemicalEntity | denotes | AMI | http://purl.obolibrary.org/obo/CHEBI_65009 | |
| T27 | 1087-1094 | ChemicalEntity | denotes | aspirin | D001241 | |
| T26 | 1053-1066 | ChemicalEntity | denotes | acetaminophen | D000082 | |
| T25 | 1032-1038 | ChemicalEntity | denotes | NSAIDs | ChemicalEntity | |
| T23 | 1009-1018 | ChemicalEntity | denotes | celecoxib | http://purl.obolibrary.org/obo/CHEBI_41423|D000068579 | |
| T21 | 988-997 | ChemicalEntity | denotes | rofecoxib | http://purl.obolibrary.org/obo/CHEBI_8887|C116926 | |
| T20 | 958-965 | ChemicalEntity | denotes | aspirin | D001241 | |
| T19 | 935-941 | ChemicalEntity | denotes | NSAIDs | ChemicalEntity | |
| T17 | 907-916 | ChemicalEntity | denotes | celecoxib | http://purl.obolibrary.org/obo/CHEBI_41423|D000068579 | |
| T15 | 887-896 | ChemicalEntity | denotes | rofecoxib | http://purl.obolibrary.org/obo/CHEBI_8887|C116926 | |
| T14 | 862-875 | ChemicalEntity | denotes | acetaminophen | D000082 | |
| T13 | 838-845 | ChemicalEntity | denotes | aspirin | D001241 | |
| T12 | 671-684 | ChemicalEntity | denotes | acetaminophen | D000082 | |
| T11 | 662-667 | ChemicalEntity | denotes | NSAID | ChemicalEntity | |
| T10 | 506-519 | ChemicalEntity | denotes | acetaminophen | D000082 | |
| T9 | 495-501 | ChemicalEntity | denotes | NSAIDs | ChemicalEntity | |
| T8 | 474-490 | ChemicalEntity | denotes | COX-2 inhibitors | ChemicalEntity | |
| T7 | 425-428 | ChemicalEntity | denotes | AMI | http://purl.obolibrary.org/obo/CHEBI_65009 | |
| T6 | 363-369 | ChemicalEntity | denotes | NSAIDs | ChemicalEntity | |
| T5 | 324-361 | ChemicalEntity | denotes | non-steroidal anti-inflammatory drugs | ChemicalEntity | |
| T4 | 227-243 | ChemicalEntity | denotes | COX-2 inhibitors | ChemicalEntity | |
| T3 | 217-220 | ChemicalEntity | denotes | AMI | http://purl.obolibrary.org/obo/CHEBI_65009 | |
| T2 | 56-62 | ChemicalEntity | denotes | NSAIDs | ChemicalEntity | |
| T1 | 22-38 | ChemicalEntity | denotes | COX-2 inhibitors | ChemicalEntity | |
| T37081 | 474-479 | GeneOrGeneProduct | denotes | COX-2 | ||
| T16034 | 227-232 | GeneOrGeneProduct | denotes | COX-2 | ||
| T13836 | 22-27 | GeneOrGeneProduct | denotes | COX-2 | ||
| T64220 | 1705-1716 | DiseaseOrPhenotypicFeature | denotes | GI toxicity | DISEASE | |
| T11476 | 1701-1704 | DiseaseOrPhenotypicFeature | denotes | AMI | DISEASE | |
| T42308 | 1687-1695 | DiseaseOrPhenotypicFeature | denotes | bleeding | D006470 | |
| T63280 | 1680-1683 | DiseaseOrPhenotypicFeature | denotes | AMI | DISEASE | |
| T47343 | 1172-1175 | DiseaseOrPhenotypicFeature | denotes | AMI | DISEASE | |
| T18308 | 436-444 | DiseaseOrPhenotypicFeature | denotes | bleeding | D006470 | |
| T36899 | 425-428 | DiseaseOrPhenotypicFeature | denotes | AMI | DISEASE | |
| T47431 | 217-220 | DiseaseOrPhenotypicFeature | denotes | AMI | DISEASE | |
| T3005 | 194-215 | DiseaseOrPhenotypicFeature | denotes | myocardial infarction | D009203 | |
| T6691 | 1701-1704 | OrganismTaxon | denotes | AMI | ||
| T2100 | 1680-1683 | OrganismTaxon | denotes | AMI | ||
| T71975 | 1172-1175 | OrganismTaxon | denotes | AMI | ||
| T94435 | 601-609 | OrganismTaxon | denotes | patients | ||
| T71946 | 459-467 | OrganismTaxon | denotes | patients | ||
| T81943 | 425-428 | OrganismTaxon | denotes | AMI | ||
| T76475 | 217-220 | OrganismTaxon | denotes | AMI |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 194-215 | HP_0001658 | denotes | myocardial infarction |